HALO
Price
$58.01
Change
+$1.41 (+2.49%)
Updated
Jul 16 closing price
Capitalization
7.15B
26 days until earnings call
NBY
Price
$0.65
Change
-$0.02 (-2.99%)
Updated
Jul 16 closing price
Capitalization
3.76M
RDUS
Price
$30.00
Change
-$0.00 (-0.00%)
Updated
Jul 10 closing price
Capitalization
847.73M
98 days until earnings call
Interact to see
Advertisement

HALO or NBY or RDUS

Header iconHALO vs NBY vs RDUS Comparison
Open Charts HALO vs NBY vs RDUSBanner chart's image
Halozyme Therapeutics
Price$58.01
Change+$1.41 (+2.49%)
Volume$1.43M
Capitalization7.15B
NovaBay Pharmaceuticals
Price$0.65
Change-$0.02 (-2.99%)
Volume$23.67K
Capitalization3.76M
Radius Recycling
Price$30.00
Change-$0.00 (-0.00%)
Volume$1.72M
Capitalization847.73M
HALO vs NBY vs RDUS Comparison Chart in %
Loading...
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (HALO: $58.01NBY: $0.65RDUS: $30.00)
Brand notoriety: HALO, NBY and RDUS are all not notable
HALO and NBY are part of the Biotechnology industry, and RDUS is in the Steel industry
Current volume relative to the 65-day Moving Average: HALO: 53%, NBY: 57%, RDUS: 219%
Market capitalization -- HALO: $7.15B, RDUS: $847.73M, NBY: $3.76M
$HALO [@Biotechnology] is valued at $7.15B. $NBY’s [@Biotechnology] market capitalization is $ $3.76M. $RDUS [@Steel] has a market capitalization of $ $847.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $ $300.78B to $ $0. The market cap for tickers in the [@Steel] industry ranges from $ $31.8B to $ $0. The average market capitalization across the [@Biotechnology] industry is $ $2.44B. The average market capitalization across the [@Steel] industry is $ $5.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 1 FA rating(s) are green whileNBY’s FA Score has 2 green FA rating(s), and RDUS’s FA Score reflects 1 green FA rating(s).

  • HALO’s FA Score: 1 green, 4 red.
  • NBY’s FA Score: 2 green, 3 red.
  • RDUS’s FA Score: 1 green, 4 red.
According to our system of comparison, NBY is a better buy in the long-term than HALO, which in turn is a better option than RDUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 4 TA indicator(s) are bullish while NBY’s TA Score has 6 bullish TA indicator(s), and RDUS’s TA Score reflects 4 bullish TA indicator(s).

  • HALO’s TA Score: 4 bullish, 6 bearish.
  • NBY’s TA Score: 6 bullish, 4 bearish.
  • RDUS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NBY is a better buy in the short-term than RDUS, which in turn is a better option than HALO.

Price Growth

HALO (@Biotechnology) experienced а +2.53% price change this week, while NBY (@Biotechnology) price change was -0.55% , and RDUS (@Steel) price fluctuated 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.56%. For the same industry, the average monthly price growth was +10.24%, and the average quarterly price growth was +39.21%.

The average weekly price growth across all stocks in the @Steel industry was -0.09%. For the same industry, the average monthly price growth was +3.66%, and the average quarterly price growth was +9.48%.

Reported Earning Dates

HALO is expected to report earnings on Nov 10, 2025.

NBY is expected to report earnings on May 15, 2025.

RDUS is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Biotechnology (+2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Steel (-0.09% weekly)

The steel industry includes manufacturers of steel and steel-related products. Companies use iron ore and scrap steel to produce steel. The industry also includes companies involved in mining and marketing of steel products. Along with serving some of the domestic markets, U.S. steel output has, over the years, been used by international economies as well. Competition from imported steel has also increased over time. The industry could be susceptible to business cycles, since the element is an important input in industrial production. Some of the globally-renowned steel behemoths include Nucor Corporation, Vale, and ArcelorMittal SA.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($7.15B) has a higher market cap than RDUS($848M) and NBY($3.76M). HALO has higher P/E ratio than NBY and RDUS: HALO (15.43) vs NBY (0.03) and RDUS (). RDUS YTD gains are higher at: 101.533 vs. HALO (21.334) and NBY (7.454). HALO has higher annual earnings (EBITDA): 705M vs. NBY (-6.8M) and RDUS (-200.1M). HALO has more cash in the bank: 748M vs. NBY (8.47M) and RDUS (5.44M). NBY has less debt than RDUS and HALO: NBY (1.13M) vs RDUS (562M) and HALO (1.51B). RDUS has higher revenues than HALO and NBY: RDUS (2.74B) vs HALO (1.08B) and NBY (9.78M).
HALONBYRDUS
Capitalization7.15B3.76M848M
EBITDA705M-6.8M-200.1M
Gain YTD21.3347.454101.533
P/E Ratio15.430.03N/A
Revenue1.08B9.78M2.74B
Total Cash748M8.47M5.44M
Total Debt1.51B1.13M562M
FUNDAMENTALS RATINGS
HALO vs NBY vs RDUS: Fundamental Ratings
HALO
NBY
RDUS
OUTLOOK RATING
1..100
4530
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
13
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
3610072
SMR RATING
1..100
121397
PRICE GROWTH RATING
1..100
555937
P/E GROWTH RATING
1..100
863680
SEASONALITY SCORE
1..100
n/an/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RDUS's Valuation (12) in the Biotechnology industry is in the same range as NBY (13) and is somewhat better than the same rating for HALO (76). This means that RDUS's stock grew similarly to NBY’s and somewhat faster than HALO’s over the last 12 months.

HALO's Profit vs Risk Rating (36) in the Biotechnology industry is somewhat better than the same rating for RDUS (72) and is somewhat better than the same rating for NBY (100). This means that HALO's stock grew somewhat faster than RDUS’s and somewhat faster than NBY’s over the last 12 months.

HALO's SMR Rating (12) in the Biotechnology industry is in the same range as NBY (13) and is significantly better than the same rating for RDUS (97). This means that HALO's stock grew similarly to NBY’s and significantly faster than RDUS’s over the last 12 months.

RDUS's Price Growth Rating (37) in the Biotechnology industry is in the same range as HALO (55) and is in the same range as NBY (59). This means that RDUS's stock grew similarly to HALO’s and similarly to NBY’s over the last 12 months.

NBY's P/E Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for RDUS (80) and is somewhat better than the same rating for HALO (86). This means that NBY's stock grew somewhat faster than RDUS’s and somewhat faster than HALO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HALONBYRDUS
RSI
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 6 days ago
82%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 17 days ago
68%
Bearish Trend 1 day ago
90%
Bearish Trend 22 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
HALO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFRM67.211.06
+1.60%
Affirm Holdings
VHI17.84-0.07
-0.39%
Valhi
KGS31.95-0.80
-2.44%
Kodiak Gas Services
ARMP2.36-0.10
-4.07%
Armata Pharmaceuticals
ALBT2.42-0.18
-6.92%
Avalon GloboCare Corp